Inventor
ANNA QUATTROPANI
Inventor
CH
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07BGeneral methods of organic chemistry5%
C12NMicroorganisms or enzymes3%
PatentTitleYear
12,398,130Acid addition salts of piperazine derivatives202512,195,455Succinate and fumarate acid addition salts of piperazine derivatives202512,187,741Glycosidase inhibitors202512,157,734Sulfoximine glycosidase inhibitors202412,016,852Pyrrolidine glycosidase inhibitors202411,795,165Tetrahydro-benzoazepine glycosidase inhibitors202311,731,972Spiro compounds as glycosidase inhibitors202311,612,599Glycosidase inhibitors202311,591,327Acid addition salts of piperazine derivatives202311,524,003Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof202211,458,140Annulated glycosidase inhibitors202211,261,183Sulfoximine glycosidase inhibitors202211,213,525Linear glycosidase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ASCENEURON SA (12)· patent assignee history
2022Patents assigned to ObsEva SA (1)· patent assignee history
2022–2025Based in CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASCENEURON SA | 12 | 2022–2025 |
| ObsEva SA | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 13 | 2022–2025 |